Infection Control Today® Editorial Staff

GigaGen, a biotech company, secures an $11.8M contract expansion with the US Department of Defense to develop synthetic human antibody treatments for botulinum neurotoxins.

Marking the World Health Organization's World AMR Awareness Week, “Going Blue: Confronting the AMR Challenge,” urges health care providers and the public to educate, follow protocols, and ensure patient safety for antibiotic efficacy.

Unlock the secrets to infection prevention in facelift surgery as renowned surgeons Dr. Konstantin Vasyukevic and Dr. Peter Lee share their expert insights and meticulous protocols in this informative interview.

Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA, and SHEA Chair, highlights IDWeek 2023's hybrid format and discusses the critical topic of antimicrobial resistance, emphasizing the role of vaccines in reducing AMR.

A study of 28 nursing homes and nearly 29,000 residents reveals that universal decolonization significantly lowered infection-related hospitalizations, offering hope for improved healthcare outcomes.

Meriwether County School District prioritizes student safety by implementing CASPR Technology, enhancing air and surface disinfection for a healthier learning environment.

Wastewater-based surveillance can accurately monitor influenza A and B and RSV at the population level. This makes it an objective tool to inform public response to common seasonal illnesses.

This edition of Infection Intel from Infection Control Today covers infection control and prevention company news out of IDWeek, being held in Boston, Massachusetts, from October 11 to 15, 2023.

Cases of COVID-19, RSV, and influenza are expected to rise this fall and winter season; yet, the number of people who plan on getting the vaccines for each of the infections remains low, according to the NFID announcement today.

Health Watch USA’s annual conference will examine many aspects of long COVID with speakers from across the globe on November 1, 2023, from 8:30 AM to 2:00 PM EST.

A recent conference highlights patient safety in health care and aims to reduce risks and harm to patients during medical care. It's a response to the growing complexity of health care systems and the resulting increase in patient harm.

All eye drops from Dr. Berne’s Whole Health Products are being recalled after FDA warning on August 24. There are 2 adverse reactions reported so far.

Contaminated eye drops can cause infections ranging from minor to life-threatening.

Eagle Pharmaceuticals randomized its first patient in the Phase 2 study of CAL02, a safe and promising anti-toxin drug that treats severe community-acquired bacterial pneumonia without contributing to antibiotic resistance.

In the upcoming fall, vaccination may be necessary for Eris (EG.5) and FL.1.5.1, as they are believed to be the variants of concern.

A new remote sexual health testing provider is available to US public health officials. It aims to reduce the increasing spread of sexually transmitted infections.

Sepsis often first appears in the emergency department, making diagnosis challenging and leading to delays. This study examines a new, recently FDA-approved test on how to diagnose earlier.

AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.

Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies.

Two investigators from Australia spoke with ICT about how management tools can overcome health care worker reluctance and implement OR safety improvements.

Joshua Rhein, MD, explains why patients who are obese are more likely to develop sepsis.

A recent literature review and meta-analysis sought to determine the effects of COVID-19 lockdown measures on mortality rates. Here's what a team of economists found.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending February 4.

Many people suffer from long COVID, and since COVID-19 is a fairly recent development experts aren’t sure what “long” means exactly. Weeks? Months? Years? A lifetime?

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 28.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 21.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 14.

The vaccine for Omicron looks promising, says Pfizer, but in the meantime, the booster remains the best shot at avoiding infection.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 7.

Just how much celebrating the pandemic-weary public can do turns on the vaccinated or unvaccinated question.